Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
Condition(s):Spinal Muscular Atrophy Type IILast Updated:June 13, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Spinal Muscular Atrophy Type IILast Updated:June 13, 2022Completed
Condition(s):Spinal Muscular AtrophyLast Updated:March 23, 2023Active, not recruiting
Condition(s):Spinal Muscular Atrophy 1Last Updated:January 5, 2024Recruiting
Condition(s):Spinal Muscular Atrophy Type I; Spinal Muscular Atrophy Type IILast Updated:February 8, 2023Active, not recruiting
Condition(s):Spinal Muscular AtrophyLast Updated:November 30, 2022Active, not recruiting
Condition(s):Spinal Muscular AtrophyLast Updated:September 13, 2021Completed
Condition(s):Spinal Muscular Atrophy Type III; Spinal Muscular Atrophy Type IILast Updated:November 18, 2023Enrolling by invitation
Condition(s):Spinal Muscular AtrophyLast Updated:December 19, 2022Recruiting
Condition(s):Spinal Muscular Atrophy Type ILast Updated:November 22, 2022Completed
Condition(s):Spinal Muscular Atrophy Type ILast Updated:November 14, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.